1[1]Extra JM, Espie M, Calvo F, et al. Phase 1 study of oxaliplatin in patient with advanced cancer[J].Cancer Chemother Pharmacol,1990,25:299-303.
2[2]De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer[J].J Clin Oncol,2000,18:2938-2947.
3[3]Becouarn Y, Ychou M, Ducreux M, et al. Phase 2 trial of oxaliplatin as first line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers[J].J Clin Oncol,1998,16:2739-2744.
4[4]Giacchetti S, Perpoint B, Zidani R, et al. Phase 3 multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil feucovorin as first line treatment of metastatic colorectal cancer[J].J Clin Oncol,2000,18:136-147.
5[5]Andre T, Bensmaine M, Louvet C, et al. Multicenter phase 2 study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen[J].J Clin Oncol,1999,17:3560-3568.
6[6]Laine-Cessac P, Boisdron-Celle M, Girault C, et al. Acute Oxaliplatin Neurotoxicity Dramatically Improved with Intravenous Calcium and Magnesium Salts[M].Nancy: Lieme Congress Annual de le Societe France de Phamacology,1998.23-25.
7[7]Gamelin E, Gamelin L, Delva R, et al. Prevention of oxaliplatin peripheral sensory neuropathy by Ca2+ gluconate/Mg2+ chloride infusion-A retrospective study[J].Proc Am Soc Clin,2002,21:157a.
8[9]Mathe G, Kidani Y, Triana K, et al. A phase 1 trial of trans-1-diaminocyclohexane oxalateplatinum (1-OHP)[J].Biomed Pharmacother,1986,40:372-376.
9[10]De Gramont A, Figer A, Seymour M, et al. Arandomised trial of leucovorin and 5-FU with or without oxaliplatin in advanced colorectal cancer[J].Proc Am Soc Clin Oncol,1998,17:257a.
10[11]Graham M, Lockwood G, Greenslade D, et al. Clinical pharmacokinetics of oxaliplatin: A critical review[J].Clin Cancer Res,2000,6:1205-1218.
